FormFactor Inc.
FORM
$115.81
-0.45%
FormFactor Inc. is a leading provider of electrical and optical test and measurement technologies for the semiconductor industry, serving the full product lifecycle from characterization to production test. The company operates through two segments: Probe Cards (including analytical probes) and Systems (probe stations and thermal subsystems), with probe cards being the primary revenue driver. As a specialized player in semiconductor test equipment, FormFactor benefits from the increasing complexity of chip designs and the proliferation of advanced packaging technologies. The current investor narrative centers on the company's strong revenue growth driven by demand for DRAM and foundry/logic test solutions, as well as margin expansion from operational leverage, though recent stock volatility reflects broader semiconductor cycle concerns.…
FORM
FormFactor Inc.
$115.81
Investment Opinion: Should I buy FORM Today?
Rating: Hold. FormFactor is a high-growth semiconductor test equipment play with strong operational momentum, but its premium valuation limits upside potential. The analyst consensus leans bullish with an average target of ~$121.7, implying only 3.6% upside from $117.52.
Supporting Evidence: Revenue grew 13.6% YoY to $215.2M, gross margin expanded 400 bps to 42.8%, and operating margin improved 900 bps to 13.1%. The forward P/E of 42.1x is above the industry average of 25x, but the P/S of 5.7x is below historical averages, suggesting sales-based valuation is more reasonable. Free cash flow of $34.7M in Q4 supports reinvestment.
Risks & Conditions: The Hold rating could upgrade to Buy if the forward P/E compresses below 35x or revenue growth accelerates above 20%. Downgrade to Sell if gross margins fall below 38% or revenue growth decelerates below 10%. Overall, the stock appears fairly valued relative to its growth prospects but overvalued on absolute P/E basis.
Sign up to view all
FORM 12-Month Price Forecast
FormFactor's strong operational performance is offset by its premium valuation and cyclical risks. The base case of steady growth is most likely, but the stock's high beta and stretched multiples make it vulnerable to corrections. Upside catalysts like earnings beats could drive the stock to $132, while a downturn could push it to $70. The neutral stance reflects balanced risk/reward at current levels.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on FormFactor Inc.'s 12-month outlook, with a consensus price target around $150.55 and implied upside of +30.0% versus the current price.
Average Target
$150.55
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$93 - $151
Analyst target range
FormFactor has coverage from 2 analysts, with a consensus recommendation leaning bullish. The average EPS estimate for the current fiscal year is $2.89, with a low of $2.65 and high of $3.14. Revenue estimates average $1.11 billion, implying continued growth. The limited analyst coverage (2 analysts) suggests the stock may be underfollowed, which can lead to higher volatility and less efficient price discovery. Institutional ratings from firms like Cantor Fitzgerald (Overweight), Citigroup (Buy), and B. Riley Securities (Buy) indicate positive sentiment, while TD Cowen and Stifel rate it Hold. The average target price is not explicitly provided, but based on the forward P/E of 42.1x and EPS estimate of $2.89, the implied target is approximately $121.7, representing about 3.6% upside from the current price of $117.52. The low EPS estimate of $2.65 implies a target of $111.6 (5% downside), while the high estimate of $3.14 implies $132.2 (12.5% upside). The relatively narrow range suggests moderate conviction among analysts. The consensus leans positive, but the modest upside indicates that much of the good news may already be priced in.
Bulls vs Bears: FORM Investment Factors
FormFactor presents a compelling growth story with strong revenue acceleration, expanding margins, and a pristine balance sheet. The company benefits from secular trends in semiconductor test complexity. However, the stock's valuation is stretched, trading at a significant premium to peers, and recent price volatility suggests market uncertainty. The bull case is supported by operational momentum and analyst optimism, while the bear case centers on valuation risk and cyclical exposure. The single most important tension is whether the company can sustain its growth trajectory to justify the premium valuation; if revenue growth decelerates or margins compress, the stock could face substantial downside.
Bullish
- Strong Revenue Growth Trajectory: Revenue grew 13.6% YoY in Q4 2025 to $215.2M, with sequential acceleration from $171.4M in Q1 2025. This growth is driven by DRAM and foundry/logic test demand, reflecting secular tailwinds from advanced chip packaging.
- Significant Margin Expansion: Gross margin expanded from 38.8% in Q4 2024 to 42.8% in Q4 2025, while operating margin surged from 4.1% to 13.1%. This demonstrates strong operating leverage as revenue scales.
- Fortress Balance Sheet: Debt-to-equity ratio is just 0.043, and the current ratio is 4.50, indicating minimal leverage and ample liquidity. This financial strength provides flexibility for R&D and M&A.
- Positive Analyst Sentiment: Consensus rating leans bullish with firms like Cantor Fitzgerald (Overweight) and Citigroup (Buy). Forward P/E of 42.1x implies expected earnings acceleration, supported by EPS estimates of $2.89 for the current year.
Bearish
- Elevated Valuation Premium: Trailing P/E of 82.9x is 232% above the semiconductor industry average of ~25x. Even forward P/E of 42.1x represents a 68% premium, leaving little room for disappointment.
- Recent Price Volatility and Correction: The stock has pulled back 26.7% from its 52-week high of $160.27 to $117.52, and the 3-month change is -5.1%. Beta of 1.217 amplifies downside risk in a market downturn.
- Limited Analyst Coverage: Only 2 analysts cover the stock, which can lead to less efficient price discovery and higher volatility. The narrow target range ($111.6-$132.2) suggests moderate conviction.
- Cyclical Semiconductor Exposure: As a semiconductor equipment supplier, FormFactor is sensitive to chip industry cycles. Any slowdown in DRAM or foundry spending could pressure revenue growth and margins.
FORM Technical Analysis
FormFactor is in a powerful long-term uptrend, with the stock up 223.7% over the past year, dramatically outperforming the S&P 500's 20.6% gain. The current price of $117.52 sits at 68.5% of its 52-week range ($26.08 low to $160.27 high), indicating the stock is in the upper half of its range but has pulled back from the highs. This positioning suggests the stock has experienced significant momentum but is currently in a corrective phase, offering a potential entry point for trend-following investors if support holds. Over the past month, the stock has gained 1.5%, while the 3-month change is -5.1%, showing a deceleration from the blistering 6-month gain of 71.2%. The divergence between the strong 1-year trend and the recent 3-month pullback could signal a temporary consolidation within a secular uptrend, or the beginning of a deeper correction if the 1-month momentum fails to re-accelerate. The stock's beta of 1.217 indicates it is 21.7% more volatile than the market, amplifying both upside and downside moves. The 52-week low of $26.08 provides a distant support level, while the 52-week high of $160.27 is the immediate resistance. A breakout above $160.27 would signal a resumption of the uptrend, while a breakdown below the recent low of $106.05 (July 7 close) could test the $100 psychological level. The stock's elevated volatility (beta >1) means position sizing should be adjusted for risk management.
Beta
1.22
1.22x market volatility
Max Drawdown
-33.7%
Largest decline past year
52-Week Range
$26-$160
Price range past year
Annual Return
+231.4%
Cumulative gain past year
| Period | FORM Return | S&P 500 |
|---|---|---|
| 1m | -24.1% | +0.0% |
| 3m | -9.3% | +7.6% |
| 6m | +47.9% | +9.1% |
| 1y | +231.4% | +21.3% |
| ytd | +95.7% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FORM Fundamental Analysis
FormFactor's revenue trajectory is robust, with the most recent quarter (Q4 2025, ending Dec 27, 2025) reporting $215.2 million, up 13.6% year-over-year from $189.5 million in Q4 2024. Revenue has grown sequentially from $171.4 million in Q1 2025 to $202.7 million in Q3 2025, indicating accelerating growth through the year. Segment data shows Foundry & Logic ($92.2M) and DRAM ($73.3M) are the primary growth drivers, while Flash ($7.4M) remains a smaller contributor. The Systems segment contributed $42.3M, highlighting diversification. This growth trajectory supports the investment case as semiconductor test complexity increases with advanced nodes. The company is profitable, with net income of $23.2 million in Q4 2025, up from $9.7 million in Q4 2024, representing a 139% increase. Gross margin expanded to 42.8% in Q4 2025 from 38.8% in the prior year quarter, reflecting operating leverage and favorable mix. Operating margin improved to 13.1% from 4.1% a year ago, demonstrating strong cost control. The net margin of 10.8% is healthy for the semiconductor equipment industry, which typically sees net margins in the 10-15% range. FormFactor maintains a fortress balance sheet with a debt-to-equity ratio of just 0.043, indicating minimal leverage. The current ratio of 4.50 provides ample liquidity. Free cash flow was $34.7 million in Q4 2025, up from $28.3 million in Q4 2024, and the company generated $11.7 million in trailing twelve-month free cash flow. ROE of 5.3% is modest but improving, and the company has no dividend, reinvesting all capital into growth. The strong cash position and low debt provide financial flexibility for R&D and potential acquisitions.
Quarterly Revenue
$215163000.0B
2025-12
Revenue YoY Growth
+13.6%
YoY Comparison
Gross Margin
42.8%
Latest Quarter
Free Cash Flow
$11740000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FORM Overvalued?
Since net income is positive ($23.2M in Q4 2025), the primary valuation metric is the P/E ratio. The trailing P/E is 82.9x, while the forward P/E is 42.1x, implying the market expects significant earnings growth. The gap between trailing and forward P/E suggests analysts anticipate a sharp earnings acceleration, which is consistent with the company's improving margins and revenue growth. Compared to the semiconductor industry average P/E of approximately 25x, FormFactor's trailing P/E of 82.9x represents a 232% premium. However, the forward P/E of 42.1x is still a 68% premium to the industry average, indicating the market is pricing in above-average growth. This premium may be justified by FormFactor's strong revenue growth (13.6% YoY) and expanding margins, but it leaves little room for disappointment. Historically, FormFactor's trailing P/E has ranged from 10.7x (Q4 2023) to 797x (Q2 2023) over the past few years, reflecting volatile earnings. The current trailing P/E of 82.9x is near the higher end of its historical range, suggesting the market is optimistic about future earnings. The P/S ratio of 5.7x is below the historical average of ~15x, indicating that on a sales basis, the stock is more reasonably valued. The EV/EBITDA of 38.6x is elevated but reflects the company's growth trajectory.
PE
82.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -31x~797x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
38.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: FormFactor's trailing P/E of 82.9x implies high earnings expectations; any miss could trigger multiple compression. While the company has low debt (D/E 0.043), its free cash flow TTM of $11.7M is modest relative to market cap, limiting reinvestment capacity. Revenue concentration in DRAM ($73.3M in Q4) and foundry/logic ($92.2M) exposes it to segment-specific downturns. The net margin of 10.8% is healthy but could be pressured by rising R&D costs (30.4% of revenue in Q4).
Market & Competitive Risks: The stock's beta of 1.217 indicates 21.7% higher volatility than the market, amplifying downside in sell-offs. At 5.7x P/S, the stock trades above historical averages, leaving it vulnerable to valuation compression if growth slows. Limited analyst coverage (2 analysts) means less institutional support. Competitive risks include technological disruption from alternative test methods or pricing pressure from larger players like Teradyne.
Worst-Case Scenario: A severe semiconductor downturn could slash revenue growth below 5%, causing margins to contract and earnings to miss estimates. In such a scenario, the stock could retest its 52-week low of $26.08, representing a 77.8% decline from the current price of $117.52. More realistically, a 30-40% correction to the $70-80 range is possible if the forward P/E compresses to 25x (industry average) on reduced EPS estimates.
FAQ
The key risks are: 1) Valuation risk: trailing P/E of 82.9x leaves little room for error; 2) Cyclical risk: as a semiconductor equipment supplier, revenue is sensitive to chip industry cycles; 3) Concentration risk: revenue is heavily weighted to DRAM and foundry/logic segments; 4) Volatility risk: beta of 1.217 means the stock amplifies market moves. The most severe risk is a semiconductor downturn that could cut revenue growth below 5% and compress the P/E multiple.
The 12-month forecast is balanced: a 25% probability of a bull case reaching $132-$160 (driven by earnings beats and margin expansion), a 50% probability of a base case trading between $112-$132 (in line with analyst targets), and a 25% probability of a bear case falling to $70-$112 (due to cyclical downturn). The most likely scenario is the base case, with the stock averaging around $121.7, assuming steady revenue growth of 10-15% and stable margins.
FormFactor's trailing P/E of 82.9x is 232% above the semiconductor industry average of 25x, suggesting overvaluation on an earnings basis. However, the forward P/E of 42.1x implies expected earnings growth, and the P/S ratio of 5.7x is below historical averages, indicating more reasonable sales-based valuation. The market is pricing in above-average growth, which may be justified by 13.6% revenue growth and expanding margins. Overall, the stock appears fairly valued relative to growth but overvalued on absolute P/E.
FormFactor is a good buy for investors with a high risk tolerance who believe in the secular growth of semiconductor test complexity. The stock offers 3.6% upside to the average analyst target of $121.7, but the trailing P/E of 82.9x is steep. The biggest downside risk is a cyclical downturn that could compress multiples and reduce earnings. For long-term growth investors, the company's strong revenue momentum and margin expansion make it a compelling hold, but near-term entry should be sized carefully given volatility.
FormFactor is better suited for long-term investment given its growth profile and volatility. The stock has a beta of 1.217, making it risky for short-term trading. The company reinvests all capital (no dividend), and its earnings visibility is tied to multi-year semiconductor trends. A minimum holding period of 3-5 years is recommended to ride out cyclical downturns. Short-term traders may find opportunities around earnings events, but the stock's 26.7% pullback from highs highlights the risk of timing the market.